XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Bad debt expense $ 0   $ 0
Amortization expense 1,013 $ 1,012  
Accumulated amortization 13,163   $ 12,150
Advertising and Marketing Costs 27,208 31,008  
Research and development expenses $ 116,251 $ 115,551  
Description of patent     straight-line basis over the estimated useful life of 10 years
Restricted Stock Units [Member]      
Potential antidilutive shares 41,440,000 47,665,000  
Convertible Notes Payable - Related Party [Member]      
Potential antidilutive shares 9,496,287 3,842,491  
Convertible Notes Payable [Member]      
Potential antidilutive shares 11,781,062 1,521,145  
Warrants [Member]      
Potential antidilutive shares 412,500